A Comprehensive Rat Model For Assessing Hepatic Transport Pathways Through Simultaneous Lymphatic And Blood Vascular Sampling
May 15th, 2026
This experimental protocol describes a hepatic lymph duct-cannulated rat model that enables direct and quantitative assessment of hepatic lymphatic and vascular drainage. The model allows simultaneous sampling of hepatic lymph and systemic blood to investigate hepatic transport, metabolism, and immune signaling, supporting studies of drug pharmacokinetics and liver-specific biology.
Our lab studies the role of the lymphatic system in inflammatory and cardiometabolic diseases and develops drug delivery strategies to target the lymphatics to treat these diseases. This protocol enables evaluation of hepatic processes, including drug metabolism, nutrient flux, immune signaling and liver response under diverse conditions. To begin, place an anesthetized male Sprague-Dawley rat weighing approximately 250-300 grams that has been successfully cannulated via the carotid artery and jugular vein in dorsal recumbency under a surgical microscope.
Make a 4-5 centimeter horizontal skin incision from the midline to the right flank, approximately 1.5-2 centimeters below the ribcage. Retract the skin and make matching incisions in the external and internal oblique muscles. Cauterize or ligate any large blood vessels encountered during the procedure.
Use saline-moistened cotton swabs to move the liver toward the diaphragm, the stomach to the left, and the small intestine inferiorly. Keep the organs retracted with saline-soaked gauze. Identify the hepatic lymph duct running parallel to and slightly caudal to the hepatic artery, medial to the right kidney and adjacent to the inferior vena cava.
Use the larger opaque or white mesenteric lymph duct as an anatomical landmark to identify the translucent and narrow hepatic lymph duct located caudally. Use straight Graefe forceps to remove the connective tissue overlying the lymph duct and vena cava. Insert the forceps through the fat bed beneath the right kidney to create a tunnel under the vena cava.
Advance the forceps until the tips emerge parallel to the hepatic lymph duct on the opposite side of the vena cava. Use the forceps to grasp the external end of the pre-prepared cannula and pull the cannula through the tunnel until its tip emerges on the opposite side. Use the Halsted Mosquito Hemostat forceps to bend the tip of a 25-gauge needle to approximately 90 degrees.
Using the bent needle, carefully puncture the hepatic lymph duct on the right side closest to the operator. Check the cannula pre-filled with anticoagulant solution and remove air bubbles, if any. Insert the beveled end approximately 2 millimeters into the duct.
Confirm lymph flow at the external end of the cannula at approximately 100 microliters per hour. Adjust or reinsert the cannula if no flow is observed. Plug the cannula at the collecting end, then apply a small drop of veterinary adhesive to secure the insertion site.
Once the adhesive is dry, confirm lymph flow through the tubing. Afterward, remove the gauze and return the organs to their original positions. Place the collection tube containing the anticoagulant solution below the cannula outlet and confirm that lymph is flowing drop-wise into the tube.
Then close the abdominal wall by suturing the internal oblique, external oblique and skin layers sequentially. Immediately after the hepatic lymph cannulation, initiate rehydration by infusing sterile saline at 1.5-3.0 milliliters per hour through the jugular vein cannula. Monitor breathing and reflexes while maintaining anesthesia via a nose cone.
After therapeutic dosing via the jugular vein cannula, collect hepatic lymph continuously into tubes containing anticoagulant solution. Replace the collection tubes hourly or as needed. Collect carotid artery blood samples at designated time points, keeping total volume below 10%of the estimated circulating blood volume before terminal sampling.
Reopen the abdominal incision to expose the upper abdominal cavity while maintaining deep anesthesia and stable respiration. Use saline-moistened gauze to gently retract the liver toward the diaphragm, the stomach to the left, and the small intestine inferiorly. Identify the hepatic artery running parallel to the hepatic lymph duct situated adjacent to the mesenteric lymph duct.
Obtain a polyvinyl cannula with an outer diameter of 0.61 millimeters and an inner diameter of 0.28 millimeters pre-filled with an anticoagulant solution and remove any air bubbles. Using curved Iris forceps, isolate a short segment of the hepatic artery. Place a 4-0 silk suture beneath the artery.
Gently lift the artery and place a second suture distal to the first. Tie the distal suture to control backflow while leaving the proximal suture untied for later closure. Using fine point micro scissors, make a small transverse incision approximately 0.5 millimeters in the artery wall between the sutures.
Use the tip of the Dumont forceps to lift the vessel flap to stabilize the vessel lumen for cannula insertion. Insert the beveled end of the polyvinyl cannula into the opening and advance the cannula approximately 2-3 millimeters. Secure the cannula by tying the proximal suture around both the vessel and cannula.
Confirm correct placement by gently aspirating a small amount of bright red arterial blood. Collect 0.5-1 milliliter of blood into a pre-labeled tube containing anticoagulant. Lymphatic recovery of intravenously administered macromolecular therapeutics across thoracic, hepatic and mesenteric lymph demonstrates the model's utility for evaluating lymphatic transport.
Hepatic lymph has a markedly lower total lipid content than thoracic and mesenteric lymph, while its protein concentration is comparable to that of the other lymph sources. This protocol enables simultaneous measurements of hepatic lymph and blood to evaluate transport, metabolism and clearance of molecules including drugs, nutrients and signals. Precise cannulation of the hepatic lymph duct is technically challenging and requires careful anatomical identification and surgical technique.
Future studies can use this technique to map hepatic transport, clearance and metabolism, advancing understanding of liver diseases and targeted therapies.
Overview
The liver functions as a central metabolic and immunologic hub, processing nutrients, xenobiotics, and immune mediators delivered via the portal vein and hepatic artery. Substances enter hepatocytes and other hepatic cells through sinusoidal capillaries, with plasma filtrate draining into the space of Disse for metabolic transformation, immune surveillance, or lymphatic drainage as hepatic lymph. This article describes a surgical rat model enabling simultaneous sampling of hepatic lymph outflow and systemic blood through cannulation of the hepatic lymph duct, carotid artery, and jugular vein. The model supports continuous hepatic lymph and arterial sampling, with jugular vein access for hydration or venous blood collection, allowing comparison between arterial and venous blood. Hepatic lymph flow rates of approximately 0.1 mL/h in anesthetized rats permit up to 8 hours of continuous lymph sampling while arterial and venous blood are sampled simultaneously. Terminal sampling of the hepatic artery and portal vein at the end of the procedure enables direct comparison of hepatic inflow, outflow, and lymphatic drainage. This versatile platform facilitates evaluation of hepatic processes such as drug pharmacokinetics, nutrient flux and metabolism, and liver-specific responses under various pathophysiological conditions.
Key Study Components
Area of Science
- Hepatology
- Physiology
- Pharmacokinetics
Background
- The liver receives dual blood supply from the portal vein (nutrient-rich intestinal blood) and hepatic artery (oxygenated systemic blood).
- Sinusoidal capillaries allow exchange between blood and hepatocytes, with plasma filtrate entering the space of Disse.
- Hepatic lymph carries metabolically modified substances and immune factors, reflecting liver function.
- Simultaneous sampling of blood and lymph enables analysis of hepatic uptake, metabolism, and secretion.
Purpose of Study
- To develop a surgical rat model for continuous and simultaneous sampling of hepatic lymph, arterial blood, and venous blood.
- To enable direct comparison of hepatic inflow (portal vein, hepatic artery), outflow (hepatic veins), and lymphatic drainage.
- To support comprehensive analysis of hepatic transport, metabolic processes, and immune signaling.
- To provide a platform for studying drug pharmacokinetics, nutrient flux, and liver-specific responses in health and disease.
Methods Used
- Surgical cannulation of the hepatic lymph duct for continuous lymphatic outflow sampling.
- Cannulation of the carotid artery for continuous arterial blood sampling.
- Cannulation of the jugular vein for hydration, fluid support, or venous blood collection.
- Terminal sampling of the hepatic artery and portal vein at experiment completion to assess hepatic inflow.
- Measurement of hepatic lymph flow rate (~0.1 mL/h) in anesthetized rats to validate model functionality.
Main Results
- Successful cannulation yielded stable hepatic lymph flow of approximately 0.1 mL/h in anesthetized rats.
- Continuous hepatic lymph sampling was maintained for up to 8 hours alongside simultaneous arterial and venous blood sampling.
- The model allowed direct comparison of arterial blood (systemic input) and hepatic lymphatic outflow (hepatically processed output).
- Terminal sampling of hepatic artery and portal vein enabled assessment of nutrient and drug inflow to the liver.
- Facilitated analysis of hepatic clearance, metabolic transformation, and immune mediator handling.
Conclusions
- The triple-cannulation rat model provides a robust system for simultaneous sampling of hepatic lymph, arterial, and venous blood.
- It enables direct comparison of hepatic inflow, outflow, and lymphatic drainage under controlled conditions.
- The model is suitable for studying hepatic transport, metabolism, immune function, and pharmacokinetics.
- Applications include evaluation of drug disposition, nutrient flux, and liver responses in physiological and pathophysiological states.
- This approach enhances mechanistic insight into liver function by integrating vascular and lymphatic sampling.
Frequently Asked Questions
Executive Industry Relevance
Simultaneous sampling of hepatic lymph and blood in a rat model enables direct, quantitative assessment of hepatic transport, clearance, and metabolic processes critical for drug discovery and translational research. This platform enhances predictive confidence in hepatic disposition, supporting mechanistic de-risking and target validation at key inflection points in the biopharma pipeline. The model's ability to compare arterial, venous, and lymphatic compartments provides enterprise-level insight into liver-specific responses and pharmacokinetics.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables mechanistic interrogation of hepatic uptake, metabolism, and clearance pathways.
- Supports functional validation of hepatic transporters and metabolic targets.
- Facilitates biological de-risking by distinguishing vascular and lymphatic contributions to compound disposition.
- Improves predictive confidence for hepatic liabilities in early-stage portfolios.
Screening & Assay Development
- Provides validated biological samples for downstream quantitative assays of metabolites, cytokines, and xenobiotics.
- Enables assay standardization by allowing direct comparison of arterial, venous, and lymphatic compartments.
- Supports reproducible, scalable workflows for compound evaluation in hepatic contexts.
- Prepares robust sample sets for high-content screening and biomarker discovery.
Translational & Preclinical Research
- Aligns preclinical models with human hepatic physiology by integrating vascular and lymphatic sampling.
- Enables translational biomarker identification through compartment-specific analysis.
- Supports risk-adjusted advancement decisions by providing comprehensive hepatic disposition data.
- Facilitates continuity from discovery through preclinical validation of liver-targeted therapies.
Pipeline & Workflow Integration
This model bridges early discovery, lead identification, and preclinical research by enabling direct, quantitative analysis of hepatic transport and metabolism across vascular and lymphatic compartments.
- Discovery Biology: Supports hypothesis testing and pathway clarification for hepatic transport and clearance mechanisms.
- Screening: Delivers reproducible, quantitative outputs for assay development and compound triage.
- Analytics: Provides multi-compartment measurements to compare inflow, outflow, and lymphatic drainage.
- Translational Research: Aligns preclinical findings with human-relevant hepatic processes and biomarker profiles.
- Enterprise Reuse: Establishes a reusable platform for diverse hepatic studies, from pharmacokinetics to immune signaling.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in hepatic disposition studies.
- Operational Value: Standardizes sampling and analysis across vascular and lymphatic compartments for reproducibility.
- Strategic Value: Enables better go/no-go decisions and capital efficiency by clarifying hepatic risk early.
- Portfolio Impact: Supports risk-adjusted prioritization and advancement of liver-targeted assets.
Implementation Considerations
- Requires surgical expertise for precise cannulation and sample collection.
- Needs analytical infrastructure for quantitative measurement of metabolites and signaling molecules.
- Demands cross-team standardization for sample handling and data integration.
- Adaptable to various disease models and experimental conditions as supported by the protocol.
- Sample volume and duration are limited by lymph flow rates and animal physiology.
